Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Fluphenazine in Advanced Multiple Myeloma
NCT00335647Phase 2Completed
- Sponsor
- Immune Control
- Start
- Jan 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluphenazine in multiple myeloma (MM), sponsored by Immune Control. Started Jan 2006; status: completed.
02
Drugs
fluphenazine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00335647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00335647.